Authors:
Malkevitch, N
McDermott, DH
Yi, YJ
Grivel, JC
Schols, D
De Clercq, E
Murphy, PM
Glushakova, S
Collman, RG
Margolis, L
Citation: N. Malkevitch et al., Coreceptor choice and T cell depletion by R5, X4, and R5X4 HIV-1 variants in CCR5-deficient (CCR5 Delta 32) and normal human lymphoid tissue, VIROLOGY, 281(2), 2001, pp. 239-247
Authors:
McDermott, DH
Halcox, JPJ
Schenke, WH
Waclawiw, MA
Merrell, MN
Epstein, N
Quyyumi, AA
Murphy, PM
Citation: Dh. Mcdermott et al., Association between polymorphism in the chemokine receptor CX3CR1 and coronary vascular endothelial dysfunction and atherosclerosis, CIRCUL RES, 89(5), 2001, pp. 401-407
Authors:
Moatti, D
Faure, S
Fumeron, F
Amara, ME
Seknadji, P
McDermott, DH
Debre, P
Aumont, MC
Murphy, PM
de Prost, D
Combadiere, C
Citation: D. Moatti et al., Polymorphism in the fractalkine receptor CX3CR1 as a genetic risk factor for coronary artery disease, BLOOD, 97(7), 2001, pp. 1925-1928
Authors:
O'Brien, TR
McDermott, DH
Ioannidis, JPA
Carrington, M
Murphy, PM
Havlir, DV
Richman, DD
Citation: Tr. O'Brien et al., Effect of chemokine receptor gene polymorphisms on the response to potent antiretroviral therapy, AIDS, 14(7), 2000, pp. 821-826
Authors:
McDermott, DH
Beecroft, MJ
Kleeberger, CA
Al-Sharif, EM
Ollier, WER
Zimmerman, PA
Boatin, BA
Leitman, SF
Detels, R
Hajeer, AH
Murphy, PM
Citation: Dh. Mcdermott et al., Chemokine RANTES promoter polymorphism affects risk of both HIV infection and disease progression in the Multicenter AIDS Cohort Study, AIDS, 14(17), 2000, pp. 2671-2678
Authors:
Faure, S
Meyer, L
Costagliola, D
Vaneensberghe, C
Genin, E
Autran, B
Delfraissy, JF
McDermott, DH
Murphy, PM
Debre, P
Theodorou, I
Combadiere, C
Citation: S. Faure et al., Rapid progression to AIDS in HIV+ individuals with a structural variant ofthe chemokine receptor CX(3)CR1, SCIENCE, 287(5461), 2000, pp. 2274-2277